
Claims data show regorafenib is prescribed earlier than guidelines advise for a good share of patients with advanced GIST, with dosing also varying widely.
HHS has awarded eight states more than $765 million in additional grant funding to establish the health insurance exchanges that are supposed to be available for consumers in 2014.
Read the full story:
Source: ModernHealthcare.com
The department awarded level-one establishment grants—which provide a year of funding to states that have already started the process to build an exchange—to California, Hawaii, Iowa and New York. Meanwhile, Connecticut, Maryland, Nevada and Vermont received level-two grants, which are awarded to states that have made more progress in their planning efforts. HHS reports that 34 states and Washington, D.C., have received establishment grants.






